Skip to main content

Find Clinical Trials

Home
Conditions
Refractory Gastroesophageal Junction Adenocarcinoma

Clinical trial condition

Refractory Gastroesophageal Junction Adenocarcinoma

Explore clinical trials studying Refractory Gastroesophageal Junction Adenocarcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Refractory Gastroesophageal Junction Adenocarcinoma trial results

Recruiting

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

NCT05733000

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +67 more
Locations: Northwestern University Chicago, Illinois, United States

View Trial Details